tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

QNCX Stock Latest News

Quince Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial and Strong Financial Position
RatingsQuince Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial and Strong Financial Position
5d ago
QNCX
Quince Therapeutics Amends Credit Facility Agreement
PremiumCompany Announcements
Quince Therapeutics Amends Credit Facility Agreement
11d ago
8K
QNCX
Quince Therapeutics price target lowered to $8 from $9 at Citizens JMP
PremiumThe Fly
Quince Therapeutics price target lowered to $8 from $9 at Citizens JMP
2M ago
QNCX
Quince Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Quince Therapeutics Reports Q2 2025 Financial Results
2M ago
QNCX
Quince Therapeutics reports Q2 EPS (34c), consensus (23c)
PremiumThe Fly
Quince Therapeutics reports Q2 EPS (34c), consensus (23c)
2M ago
QNCX
QNCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsQNCX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
QNCX
Quince Therapeutics initiated with an Outperform at Citizens JMP
Premium
The Fly
Quince Therapeutics initiated with an Outperform at Citizens JMP
2M ago
QNCX
Quince Therapeutics files to sell 6.67M shares of common stock for holders
Premium
The Fly
Quince Therapeutics files to sell 6.67M shares of common stock for holders
2M ago
QNCX
Quince Therapeutics Completes Enrollment for Phase 3 Trial
PremiumCompany Announcements
Quince Therapeutics Completes Enrollment for Phase 3 Trial
3M ago
8K
QNCX
Quince Therapeutics completes enrollment in NEAT clinical trial
PremiumThe Fly
Quince Therapeutics completes enrollment in NEAT clinical trial
3M ago
QNCX
Quince Therapeutics initiated with a Buy at Lucid Capital
PremiumThe Fly
Quince Therapeutics initiated with a Buy at Lucid Capital
3M ago
QNCX
Quince Therapeutics Raises $11.5M in Private Placement
PremiumCompany Announcements
Quince Therapeutics Raises $11.5M in Private Placement
4M ago
8K
QNCX
Quince Therapeutics prices up to $22M placement of securities
PremiumThe FlyQuince Therapeutics prices up to $22M placement of securities
4M ago
QNCX
Quince Therapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Quince Therapeutics Approves Key Proposals at Annual Meeting
4M ago
8K
QNCX
Quince Therapeutics tops 75% enrollment in pivotal Phase 3 NEAT clinical trial
Premium
The Fly
Quince Therapeutics tops 75% enrollment in pivotal Phase 3 NEAT clinical trial
4M ago
QNCX
Quince Therapeutics Reports Q1 2025 Results and Strategic Updates
PremiumCompany Announcements
Quince Therapeutics Reports Q1 2025 Results and Strategic Updates
5M ago
QNCX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
MRK
ATHE
Oppenheimer Predicts Up to ~840% Surge for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Oppenheimer Predicts Up to ~840% Surge for These 2 ‘Strong Buy’ Stocks
5M ago
QNCX
SRPT
Quince Therapeutics Reports 2024 Financial Results and Trial Progress
PremiumCompany Announcements
Quince Therapeutics Reports 2024 Financial Results and Trial Progress
7M ago
QNCX
Quince Therapeutics price target lowered to $4 from $12 at D. Boral Capital
PremiumThe FlyQuince Therapeutics price target lowered to $4 from $12 at D. Boral Capital
7M ago
QNCX
Quince Therapeutics reports FY24 EPS ($1.31), one estimate ($1.17)
Premium
The Fly
Quince Therapeutics reports FY24 EPS ($1.31), one estimate ($1.17)
7M ago
QNCX
Quince Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
Quince Therapeutics initiated with an Outperform at Oppenheimer
7M ago
QNCX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >